e-learning
resources
Stockholm 2007
Monday 17.09.2007
Pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis
C. Billings, C. A. Elliot, I. Armstrong, L. Smith, M. Akil, D. G. Kiely (Sheffield, United Kingdom)
Source:
Annual Congress 2007 - Pulmonary hypertension
Session:
Pulmonary hypertension
Session type:
Thematic Poster Session
Number:
2084
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Billings, C. A. Elliot, I. Armstrong, L. Smith, M. Akil, D. G. Kiely (Sheffield, United Kingdom). Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis. Eur Respir J 2007; 30: Suppl. 51, 2084
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Gas transfer measurement in systemic sclerosis associated pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010
Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018
Year: 2018
Differences between limited and diffuse systemic sclerosis-related pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Systemic consequences of pulmonary arterial hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019
Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018
Acute haemodynamics and gas exchange of CTEPH and pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Improving survival in pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 218-220
Year: 2005
Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
Source: ERJ Open Res, 6 (2) 00309-2019; 10.1183/23120541.00309-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept